NL-OMON20177招募中不适用
Treatment of post bariatric hypoglycemia in daily practice : a prospective observational study in the Netherlands
cnter obesity north netherlands / medical center leeuwarden0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •either (Roux-en-Y gastric bypass) RYGB or OAGB (mini-gastric bypass)
- •-documented hypoglycemia with self measured glucose (SMBG) < 3.0 mM or blinded continuous glucose monitoring (cgm) 2.8 mM
- •-neuroglycopenic symptoms : behavioral changes, confusion, loss of consciousness, seizures
- •-symptom resolution after normalization of blood glucose
- •-hypoglycemic episodes despite adequate dietary advice* and interfering with daily activities, socially and/or work-related
- •-willingness to participate
排除标准
- •-current diabetes
- •-Addison’s disease or glucocorticoid use
- •-pregnancy
研究者
相似试验
进行中（未招募）
1 期
Treatment of blood sugar variations in patients with prior gastric bypass surgeryPostprandial reactive hypoglycemia in patients with prior Roux-en-Y gastric bypass surgery.MedDRA version: 18.1Level: LLTClassification code 10059038Term: Postprandial hypoglycemiaSystem Organ Class: 100000004861EUCTR2015-001086-50-DKKøge Sygehus
尚未招募
不适用
Hypoglycemia in post-bariatric vs. non-bariatric pregnancy: incidence and effects on fetal growthlow blood sugar10018424hypoglycemia1001684910017998NL-OMON56907Medisch Centrum Leeuwarden174
已完成
不适用
Reduction of severe hypoglycaemia with continuous intraperitoneal insulin infusion in type one diabetic patients unsuccessfully treated by continuous subcutaneous insulin infusioDiabetes mellitusDiabetes mellitus type oneNutritional, Metabolic, EndocrineISRCTN68954085Disetronic Medical Systems AG (Switzerland)62
已完成
不适用
Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-StudyPostprandial HypoglycemiaBariatric SurgeryLate Dumping SyndromeNCT03200782University Hospital, Basel, Switzerland12
已完成
不适用
Effect of oral hypoglycemic agent for postprandial hyperglycemia administered two times daily on glycemic control in patients with type 2 diabetes with Mitiglinide / Voglibose combination tabletsType 2 diabetesJPRN-UMIN000026185St.Marianna University School of Medicine50